Cardinal Health (CAH)
123.66
-4.60 (-3.59%)
Cardinal Health is a global healthcare services and products company that plays a vital role in the medical supply chain
It specializes in the distribution of pharmaceuticals and medical supplies to healthcare institutions, pharmacies, and patients. In addition to its distribution services, the company also manufactures and provides a wide range of medical and surgical products, including surgical gloves, apparel, and other healthcare-related items. Cardinal Health is committed to enhancing patient care by ensuring the availability of essential products and services, while also striving to improve the efficiency and effectiveness of healthcare delivery across various settings.
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent, Zircaix®2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval.
By Telix Pharmaceuticals Limited · Via GlobeNewswire · September 17, 2024
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSESYK) is a beneficiary of the acute care boom occurring in the healthcare industry.
Via MarketBeat · August 7, 2024
For Cardinal Health, the Proof Will be in Its Performance
CAH stock is up after mixed earnings that investors hope is enough to hold support after the company announced its contract for OptumRx will expire in June
Via MarketBeat · May 3, 2024
Cardinal Health Inc. (NYSE: CAH) Sets New 52-Week High in Tuesday Session
Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $114.82. So far today, approximately 39,979 shares have been exchanged, as compared to an average 30-day volume of 2.48M shares.
Via Investor Brand Network · March 12, 2024
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.
Via Investor Brand Network · January 31, 2024
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via MarketBeat · November 28, 2023
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.
Via Investor Brand Network · November 8, 2023
Cardinal Health Inc. (NYSE: CAH) Records 52-Week High Friday Morning
Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.
Via Investor Brand Network · November 3, 2023
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.
Via MarketBeat · October 9, 2023
3 Healthcare Stocks to Help Your Portfolio Get Well
Many investors look at healthcare stocks, and particularly health insurance stocks, as the right prescription for an ailing portfolio
Via MarketBeat · August 16, 2023
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $94.25. So far today, approximately 578.71k shares have been exchanged, as compared to an average 30-day volume of 2.95M shares.
Via Investor Brand Network · June 28, 2023
Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer
CLEVELAND, June 26, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective today, as Senior Vice President and Chief Financial Officer (“CFO”). Mr. Lyons recently served as Vice President, Corporate FP&A for Owens Corning (NYSEOC), a nearly $10 billion global building and construction materials leader. Prior to this role, Mr. Lyons was Vice President and Finance leader for Owens Corning’s $3.7 billion Insulation business and the company’s $2.7 billion Composites business. He was previously also the company’s Treasurer. Mr. Lyons has also held several senior leadership roles in treasury, FP&A, investor relations and tax during his 8-year career at Cardinal Health NYSE: CAHNYSECAH)
By Sotera Health Services, LLC · Via GlobeNewswire · June 26, 2023
Can Cardinal Health Fly Higher In 2023?
Cardinal Health is on the rise after raising guidance and announcing a new repurchase program worth more than 10% of the market cap.
Via MarketBeat · June 12, 2023
Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
LONDON, April 27, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced it has selected Cardinal Health Inc. (NYSECAH) to support the launch and commercialization of its CAR T-cell therapies in the United States, subject to FDA approval.
By Autolus Therapeutics plc · Via GlobeNewswire · April 27, 2023
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
Via MarketBeat · March 14, 2023
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga
Via TheNewswire.com · March 1, 2023
RxLive and Cardinal Health’s Outcomes collaborate to enhance connectivity between providers across transitions of care
Collaboration connects My.RxLive tool to the OutcomesOne™ platform to improve communication and drive better patient outcomes, reducing readmission and unnecessary cost.
By RxLive · Via GlobeNewswire · February 16, 2023
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga
Via TheNewswire.com · January 17, 2023
MarketBeat: Week in Review 10/17-10/21
Stocks are staging a rally to end the week. But economic data next week may bring more volatility. Here are some of the most popular articles from this week
Via MarketBeat · October 22, 2022
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
EQNX::TICKER_START (NASDAQSTSS),NYSE:BDXNYSEBDX)(NYSE:CAHNYSECAH,(NYSE:NVONYSE),(OTCPK:TRUMY),(NASDAQ:STSSWSTSSW) EQNX::TICKER_END
Via FinancialNewsMedia · January 12, 2023
Cardinal Health Clears Base, But Can It Maintain Uptrend?
Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday.
Via MarketBeat · October 20, 2022
Shares of Cardinal Health Inc. (CAH) Rise Above Previous 52-Week High
Shares of Cardinal Health Inc. (NYSECAH) traded today at $72.28, eclipsing its 52-week high. This new high was reached on below average trading volume as 830,000 shares traded hands, while the average 30-day volume is approximately 2.9 million shares.
Via Investor Brand Network · September 2, 2022
Can Pinterest Rally On Support From Big Investor With Conviction?
Social media companies have been hit hard and Pinterest is no exception. But its biggest investor, which holds a 9% stake, voiced confidence in the company.
Via MarketBeat · August 31, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients
Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem
By RxLive · Via GlobeNewswire · July 26, 2022
Distributors Agree to Opioid Settlement With Washington State
AmerisourceBergen (NYSEABC), Cardinal Health NYSE: CAHNYSECAH)(NYSE: MCKNYSEMCK announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington’s allocation under the previously announced comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities, as well as certain attorneys’ fees and costs.
By McKesson Corporation · Via Business Wire · May 3, 2022